Methods for determining complexes of tumor rejection antigens an

Details Methods for determining complexes of tumor rejection antigens an Methods for determining complexes of tumor rejection antigens an

1998-03-11

2000-08-29

Saunders, David

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

435 721, 435 724, G01N 33574

Patent

active

061106941

ABSTRACT:
A family of tumor rejection antigen precursors, and the nucleic acid molecules which code for them, are disclosed. These tumor rejection antigen precursors are referred to as BAGE tumor rejection antigen precursors, and the nucleic acid molecules which code for them are referred to as BAGE coding molecules. Various diagnostic and therapeutic uses of the coding sequences and the tumor rejection antigen precursor molecules are described.

REFERENCES:
patent: 5683886 (1997-11-01), Van Der Bruggen
Van Der Bruggen et al, Europ. Jour. Immunol., 24 2134-2140, 1994.

Affiliated with

Also associated with

Rating

Methods for determining complexes of tumor rejection antigens an does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for determining complexes of tumor rejection antigens an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for determining complexes of tumor rejection antigens an will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1248487